FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022943584> ?p ?o ?g. }

• W2022943584 endingPage "675" @default.
• W2022943584 startingPage "667" @default.
• W2022943584 abstract "Even in the era of multitargeted therapies, cytokines remain at least one of different treatment options in renal cell cancer (RCC), particularly for patients belonging to the good prognostic risk category according to Memorial Sloan Kettering Cancer Center criteria. Granulocyte macrophage-colony stimulating factor plays a central role in the differentiation and activation of antigen presenting cells. This clinical phase 1/2 chemoimmunotherapy trial in metastatic RCC used sequential application of α-interferon /5-fluorouracil followed by granulocyte macrophage-colony stimulating factor/interleukin-2. The study was performed before multikinase inhibitors were available for routine use. Twenty patients with metastatic RCC were enrolled into this phase 1/2 protocol. Sequential chemoimmunotherapy was feasible and safe on an outpatient basis. The regimen had only modest antitumor activity with 4 mixed responses and 4 stable diseases being documented after 4 treatment cycles. Enhanced proliferative and stimulatory capacity of peripheral blood mononuclear cells was only observed in patients with mixed responses/stable diseases whereas patients with progressive disease did not show any change. Most interestingly, there was a significant increase of T cells expressing the costimulatory molecules CD80/86 in patients with progressive disease. This finding is reported here for the first time under chemoimmunotherapy of RCC. In conclusion, clinical response rates of this cytokine-based regimen do not justify further clinical evaluation. However, the study suggests that CD80/86+ T cells might have negative regulatory function under cytokine treatment and are possibly useful as a negative predictive marker for clinical response." @default.
• W2022943584 created "2016-06-24" @default.
• W2022943584 creator A5013866174 @default.
• W2022943584 creator A5060811966 @default.
• W2022943584 creator A5064559513 @default.
• W2022943584 creator A5065125026 @default.
• W2022943584 creator A5086465315 @default.
• W2022943584 date "2009-07-01" @default.
• W2022943584 modified "2023-10-18" @default.
• W2022943584 title "Granulocyte Macrophage-Colony Stimulating Factor Plus Interleukin-2 Plus α-interferon Plus 5-Fluorouracil in the Treatment of Metastatic Renal Cell Cancer" @default.
• W2022943584 cites W1484121218 @default.
• W2022943584 cites W1524157743 @default.
• W2022943584 cites W1769511668 @default.
• W2022943584 cites W1885335952 @default.
• W2022943584 cites W1928193662 @default.
• W2022943584 cites W1971393765 @default.
• W2022943584 cites W1975916906 @default.
• W2022943584 cites W1977918150 @default.
• W2022943584 cites W1979413882 @default.
• W2022943584 cites W1984328540 @default.
• W2022943584 cites W1988828691 @default.
• W2022943584 cites W1989553810 @default.
• W2022943584 cites W1990891388 @default.
• W2022943584 cites W2000577214 @default.
• W2022943584 cites W2016374131 @default.
• W2022943584 cites W2019546595 @default.
• W2022943584 cites W2047800730 @default.
• W2022943584 cites W2048715329 @default.
• W2022943584 cites W2055662879 @default.
• W2022943584 cites W2060094878 @default.
• W2022943584 cites W2066953540 @default.
• W2022943584 cites W2071378220 @default.
• W2022943584 cites W2083040816 @default.
• W2022943584 cites W2083186630 @default.
• W2022943584 cites W2086347966 @default.
• W2022943584 cites W2095041194 @default.
• W2022943584 cites W2097356332 @default.
• W2022943584 cites W2100669312 @default.
• W2022943584 cites W2123292645 @default.
• W2022943584 cites W2124376809 @default.
• W2022943584 cites W2131633419 @default.
• W2022943584 cites W213700823 @default.
• W2022943584 cites W2142052493 @default.
• W2022943584 cites W2147734974 @default.
• W2022943584 cites W2160785529 @default.
• W2022943584 cites W2321037196 @default.
• W2022943584 cites W2333642791 @default.
• W2022943584 cites W4298379398 @default.
• W2022943584 cites W4302584220 @default.
• W2022943584 doi "https://doi.org/10.1097/cji.0b013e3181a950e5" @default.
• W2022943584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19483643" @default.
• W2022943584 hasPublicationYear "2009" @default.
• W2022943584 type Work @default.
• W2022943584 sameAs 2022943584 @default.
• W2022943584 citedByCount "4" @default.
• W2022943584 countsByYear W20229435842012 @default.
• W2022943584 countsByYear W20229435842013 @default.
• W2022943584 countsByYear W20229435842014 @default.
• W2022943584 countsByYear W20229435842019 @default.
• W2022943584 crossrefType "journal-article" @default.
• W2022943584 hasAuthorship W2022943584A5013866174 @default.
• W2022943584 hasAuthorship W2022943584A5060811966 @default.
• W2022943584 hasAuthorship W2022943584A5064559513 @default.
• W2022943584 hasAuthorship W2022943584A5065125026 @default.
• W2022943584 hasAuthorship W2022943584A5086465315 @default.
• W2022943584 hasConcept C121608353 @default.
• W2022943584 hasConcept C126322002 @default.
• W2022943584 hasConcept C143998085 @default.
• W2022943584 hasConcept C154317977 @default.
• W2022943584 hasConcept C202751555 @default.
• W2022943584 hasConcept C203014093 @default.
• W2022943584 hasConcept C2776694085 @default.
• W2022943584 hasConcept C2777478134 @default.
• W2022943584 hasConcept C2777701055 @default.
• W2022943584 hasConcept C2777767877 @default.
• W2022943584 hasConcept C2778297628 @default.
• W2022943584 hasConcept C2778690821 @default.
• W2022943584 hasConcept C2778822529 @default.
• W2022943584 hasConcept C2780790343 @default.
• W2022943584 hasConcept C39347974 @default.
• W2022943584 hasConcept C502942594 @default.
• W2022943584 hasConcept C55493867 @default.
• W2022943584 hasConcept C71924100 @default.
• W2022943584 hasConcept C86803240 @default.
• W2022943584 hasConceptScore W2022943584C121608353 @default.
• W2022943584 hasConceptScore W2022943584C126322002 @default.
• W2022943584 hasConceptScore W2022943584C143998085 @default.
• W2022943584 hasConceptScore W2022943584C154317977 @default.
• W2022943584 hasConceptScore W2022943584C202751555 @default.
• W2022943584 hasConceptScore W2022943584C203014093 @default.
• W2022943584 hasConceptScore W2022943584C2776694085 @default.
• W2022943584 hasConceptScore W2022943584C2777478134 @default.
• W2022943584 hasConceptScore W2022943584C2777701055 @default.
• W2022943584 hasConceptScore W2022943584C2777767877 @default.
• W2022943584 hasConceptScore W2022943584C2778297628 @default.
• W2022943584 hasConceptScore W2022943584C2778690821 @default.
• W2022943584 hasConceptScore W2022943584C2778822529 @default.
• W2022943584 hasConceptScore W2022943584C2780790343 @default.

• next